SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy
11 references·1 citing·35 second hop
Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy (2009)Socioeconomic burden of amyotrophic later…Costs and quality of life of multiple sclerosis in Spain (2006)Costs and quality of life of …Costs and quality of life in multiple sclerosis (2006)Costs and quality of life in …Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation - ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG) (2005)Empirische Bewertungssätze in…Cost-of-illness analysis (2005)Cost-of-illness analysisCost of Illness and its Predictors for Parkinson??s Disease in Germany (2005)Cost of Illness and its Predi…Health economic evaluation (2002)Health economic evaluationAnalysis of cost data in randomized trials: an application of the non-parametric bootstrap (2000)Analysis of cost data in rand…Guidelines for Pharmacoeconomic Studies (1997)Guidelines for Pharmacoeconom…Panel on cost-effectiveness in health and medicine. (1996)Panel on cost-effectiveness i…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Guidelines for pharmacoeconomic studies. (1992)Guidelines for pharmacoeconom…Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany (2014)Comparative cost of illness a…Design of Experiments (1936)How should cost data in pragmatic randomised trials be analysed? (2000)Methods for the Economic Evaluation of Health Care Programmes (2005)Children in foster care: Mental health, service use and costs (2006)Societal Burden of Clinically Anxious Youth Referred for Treatment: A Cost-of-illness Study (2008)Cost‐of‐illness studies and cost‐effectiveness analyses in eating disorders: A systematic review (2012)EuroQol - a new facility for the measurement of health-related quality of life (1990)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Cost of Disorders of the Brain in Spain (2014)Cost of Illness of Multiple Sclerosis - A Systematic Review (2016)US Valuation of the EQ-5D Health States (2005)The cost of multiple sclerosis drugs in the US and the pharmaceutical industry (2015)Methods for the economic evaluation of health care programmes (1987)Cost of stroke in the United Kingdom (2008)Cost-of-Illness Studies (2011)The cost of mental disorders: a systematic review (2020)An Inventory for Measuring Depression (1961)The economic burden of cancer in Korea in 2002 (2007)Older Adults' Reasons for Using Technology while Aging in Place (2015)Dynamics of a stressful encounter: Cognitive appraisal, coping, and encounter outcomes. (1986)Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES (2003)Health Care Economic Analyses and Value-Based Medicine (2003)Searching for the structure of coping: A review and critique of category systems for classifying ways of coping. (2003)Systematic review of economic analyses of health care-associated infections (2005)Using thematic analysis in psychology (2006)Pharmacoeconomic Analyses Using Discrete Event Simulation (2005)Risk of bias in model-based economic evaluations: the ECOBIAS checklist (2015)EQ-5D in Central and Eastern Europe: 2000–2015 (2016)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Costs of illness and care in Parkinson's Disease: An evaluation in six countries (2010)Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg (2012)UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS (2012)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2000Analysis of cost data in randomized trials: an application of the non-parametric bootstrap691 cited
  • 2005Cost-of-illness analysis545 cited
  • 1996Panel on cost-effectiveness in health and medicine.492 cited
  • 2006Costs and quality of life in multiple sclerosis286 cited
  • 1997Guidelines for Pharmacoeconomic Studies233 cited
  • 2005Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation - ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG)226 cited
  • 1992Guidelines for pharmacoeconomic studies.224 cited
  • 2006Costs and quality of life of multiple sclerosis in Spain177 cited
  • 2005Cost of Illness and its Predictors for Parkinson??s Disease in Germany144 cited
  • 2002Health economic evaluation124 cited

Cited by

  • 2014Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany90 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work